2020 Media Kit

Journal of Immunotherapy

  • 44 Total Subscribers
  • 5,584 Average Monthly Visits

Website

http://www.immunotherapy-journal.com/

Content Focus

Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. Journal of Immunotherapy contains full-length articles, review articles, and short communications.

Impact Factor

4.110

Impact Factor Ranking

Oncology 85/244
Immunology 56/158
Medicine, Research, and Experimental 47/138

Editor-in-Chief

Steven A. Rosenberg, MD, PhD

Frequency

9 issues per year

Advertising Guidelines

Subject to approval by Editor. New copy must be received by the Publisher two weeks before closing date.